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ABSTRACT
Guanine-rich DNA of a particular sequence
adopts four-stranded structural forms known as
G-quadruplex or G4 DNA. Though in vitro forma-
tion of G4 DNA is known for several years, in vivo
presence of G4 DNA was only recently noted in
eukaryote telomeres. Recent bioinformatics ana-
lyses showing prevalence of G4 DNA within pro-
moters of human and related species seems to
implicate G4 DNA in a genome-wide cis-regulatory
role. Herein we demonstrate that G4 DNA may pres-
ent regulatory sites on a genome-wide scale by
showing widespread effect on gene expression in
response to the established intracellular G4 DNA-
binding ligands. This is particularly relevant to
genes that harbor conserved potential G4 DNA
(PG4 DNA) forming sequence across human,
mouse and rat promoters of orthologous genes.
Genes with conserved PG4 DNA in promoters
show co-regulated expression in 79 human and 61
mouse normal tissues (z-score>3.5; P<0.0001).
Conservation of G4 DNA across related species
also emphasizes the biological importance of G4
DNA and its role in transcriptional regulation of
genes; shedding light on a relatively novel mecha-
nism of regulation of gene expression in eukaryotes.
INTRODUCTION
Since the discovery of DNA as a double-helical B-DNA
molecule, many other non B- forms of DNA have been
observed (1). Among these the four-stranded guanine-rich
motif, G-quadruplex or G4 DNA adopted by particular
G-rich sequences have gained substantial attention in
recent times as potential targets for cancer therapy (1–4).
The four-stranded structure of G4 DNA is stabilized
by hydrogen-bonding between guanines present in a
co-planar arrangement called tetrads (5). Though G4
DNA forms were ﬁrst noted almost two decades back
(6–8), evidence of in vivo formation of G4 DNA was
observed only recently in telomeric ends in a cell-cycle-
dependent fashion (9) along with other evidence of
intracellular presence (10,11). Direct evidence of in vivo
existence of G4 DNA at the telomeric regions in humans
was shown by Chang et al. (10) by probing G4 DNA
by a ﬂuorescent compound BMVC (3,6-bis(1-methyl-
4-vinylpyridinium)carbazole diiodide. BMVC ﬂuorescence
increases as it binds to DNA; additionally it gives distinct
ﬂuorescence emissions for binding with G4 DNA and
duplex DNA (around 575 and 545nm, respectively) thus
enabling detection of G4 DNA-speciﬁc BMVC binding.
This study also indicated other possible G4 DNA forma-
tion sites in the genome, besides the telomeric ends. In
another independent study, G4 DNA existence inside
cells was demonstrated using an antibody speciﬁc for telo-
meric G4 DNA in Stylonychia lemnae nuclei (11).
Telomeric G4 DNA as a potential therapeutic target in
cancer has been reported by several groups (12). Telomeres
are composed of tandem repeats of d(TTAGGG) which
may extend up to 25kb in length. These regions have a
characteristic single-stranded overhang of about 100–150
bases with a propensity to form G4 DNA structures (12).
Ligand-induced stabilization of G4 DNA at the telomeric
ends inhibits telomerase (a ribonucleoprotein that is crucial
for telomere maintenance) causing cell-death (13). In this
context, molecules like PIPER (N,N0-bis[2-(1-piperidino)-
ethyl]-3,4,9,10-perylenetetracarboxylic diimide) (14), the
cationic porphyrin TMPyP4 (15) and anthraquinone ana-
logs (16) which target G4 DNA and stabilize them are
interesting potential anticancer drugs (13). TMPyP4 as
an anticancer molecule is extensively studied (15,17,18),
which is primarily due to its binding with telomeric G4
DNA resulting in inhibition of telomerase activity.
Role of G4 DNA in regulation of several genes has been
either demonstrated or predicted. G-quartet formation in
the insulin-linked polymorphic region upstream of the
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where single/double mutations that disrupted the quartet
structure gave reduced promoter activity (19). On the
other hand, G4 DNA could also be a ‘silencer element’
as demonstrated by Siddiqui-Jain et al. (20) in case of
regulation of the proto-oncogene c-MYC. Speciﬁc substi-
tutions that disrupted the structure of G4 DNA within the
c-MYC promoter gave increased promoter activity; while
stabilization of the G4 DNA by TMPyP4 decreased tran-
scription by several folds (20). Recently, it was also dem-
onstrated that TMPyP4-mediated stabilization of G4
DNA found within the NHE of PDGF-A can silence
PDGF-A expression (21). In a similar way, G4 DNA for-
mation by d(CGG) repeats within the 50-untranslated
region of the ﬁrst exon of FMR1 gene could contribute
to silencing of the gene resulting in the neurological dis-
order fragile X syndrome (22). However, in contrast to
above cases, here TMPyP4 was observed to destabilize
the G4 DNA motif (23). Therefore, eﬀect of TMPyP4
on G4 DNA demonstrates the regulatory role of
TMPyP4-mediated stabilization or destabilization of G4
DNA. Several other oncogenes, including c-KIT (24),
KRAS (25), VEGF (26), BCL-2 (27) and retinoblastoma
susceptibility gene (Rb) (28) have also been shown to
possess G4 DNA as a potential transcription regula-
tory element. Interestingly, recent studies show the role
of G4 RNA in regulation of NRAS translation (29)
and expression of other genes (30).
In addition to its role in transcription regulation, G4
DNA has been observed to be associated with several of
the genetic diseases like Werner syndrome, Bloom syn-
drome and Rothmund–Thomson syndrome (31), which
are characterized by chromosomal instability caused by
unusual changes in RecQ helicase proteins like WRN,
BLM and RECQ4. These and several other proteins like
thrombin (32), MyoD (33,34), DNA topoisomerase 1 (35)
and G Quartet Nuclease1 (GQN1) (36) that interact with
G4 DNA in humans further indicate the physiological
importance of G4 DNA.
It is interesting to note that recent whole-genome
in silico analysis revealed high occurrence of G4 DNA in
both prokaryotes (37) and eukaryotes (38–41). In pro-
karyotes, the study indicated that G4 DNA was conserved
across diﬀerent genomes, and its occurrence was enriched
in regions near the transcription start sites (TSS) (37). In
humans also in silico analysis showed that the occurrence
of G4 DNA was higher in regulatory regions (promoters)
as compared to others regions of the genome (39,40,42).
These studies implicate G4 DNA in genome-wide regula-
tion as a cis-regulatory element. In view of the above evi-
dence, we researched the role of G4 DNA in genome-wide
gene regulation in the present study by using whole-
genome expression microarrays in two diﬀerent cell lines
when treated with the G4 DNA ligand TMPyP4.
MATERIAL AND METHODS
cDNA microarray and hybridization
cDNA Microarrays representing 19200 single spotted
clones of human genes that represent about 7029 unique
genes from University Health Network Microarray Centre
(UHN, Canada) were used in the present study. RNA
was isolated from treated (100mM TMPyP4; 48hr) and
untreated HeLa S3 cells and A549 cells using TRIZOL
reagent (Sigma) as per manufacturer’s protocol. Ten
micrograms of RNA were converted to cDNA using
Microarray cDNA Synthesis Kit (ROCHE), as per man-
ufacturer’s protocol. Puriﬁed cDNA was labeled with
either Cy5 or Cy3 dyes (Amersham Biosciences) with the
help of RNA target synthesis kit T7 (Roche) as per man-
ufacturer’s protocol. The untreated control samples were
labeled with Cy3 and the treated samples were labeled
with Cy5. Labeling was reversed in case of dye-swap
reactions. Labeled product was puriﬁed with Microarray
Target Puriﬁcation Kit (Roche) as per manufacturer’s
protocol. For each cell line four replicate experiments
were done, consisting of two standard replicate arrays
and two dye-swap arrays. The labeled cRNA, both Cy3
and Cy5 labeled, were pooled together and precipitated
with ammonium acetate and the dried pellet dissolved in
18 M RNAse free water (Sigma). The labeled product
was loaded onto the slides and the hybridization was done
in presence of Dig Easy hybridization buﬀer (Roche),
10mg/ml salmon testis DNA (Sigma) and 10 mg/ml
yeast tRNA (Sigma), at 378C for 16h. Slides were
washed three times (15min each) with 1  SSC and 0.1%
SDS at 508C with occasional swirling, followed by three
washes with 1  SSC at room temperature (15min each).
Final two washes were done with 0.1  SSC for 15min
each. The slides were dried and scanned at 10-mm resolu-
tion with GenePix 4000A Microarray Scanner (Molecular
Devices), using lasers for both Cy3 and Cy5 dyes.
Microarray datafiltering andanalysis
Array images were scanned using GenePix 4000A
Microarray Scanner (Molecular Devices), using both
green and red lasers. The 16-bit TIFF images were pre-
processed and quantiﬁed using Gene Pix Pro 6.0 (Molec-
ular Devices). Data normalization was performed using
Acuity 4.0 (Molecular Devices). Data were normalized
so that the mean of the ratio of medians (635/532) of all
features is equal to 1. Data were expressed as the log2
ratio of the samples and the reference for each spot on
the array. Data were ﬁltered to include only those ele-
ments which contained only a small percentage (<3) of
saturated pixels, were not ﬂagged bad or found absent
(ﬂags 0), had relatively uniform intensity and uniform
background [Rgn R2 (635/532) 0.6] and were detectable
above background (SNR 3). Analyzable spots in at least
six of eight expression arrays performed (four each in
HeLa S3 and A549) were retrieved for downstream ana-
lysis using Signiﬁcance Analysis of Microarrays [SAM
2.21, Excel Add-In, Stanford (43)] under the conditions
of one class response and 100 permutations, with data
input parameters kept at the default values. The results
from SAM analysis include a SAM score and false dis-
covery rate (q-value). Diﬀerentially expressed genes
were retrieved at a cutoﬀ of  20% False Discovery
Rate (FDR).
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Two-step real-time RT-PCR was performed to validate
the microarray results as determined by SAM analysis.
Cells were treated with the small molecule ligands
TMPyP4, TpPy, BMVC or TMPyP2 and RNA was iso-
lated using TRIZOL reagent (Sigma) and ﬁrst-strand
cDNA synthesis was done using 2.0mg of total RNA
with cDNA Reverse Transcription Kit (Applied Bio-
systems) at 378C for 2h. Relative quantitative real-time
RT-PCR was subsequently performed with an Applied
Biosystems 7900 system and SYBR Green Master Mix
(Applied Biosystems), as per manufacturer’s protocol.
Reverse and forward primer sequences for the genes of
interest were designed using Primer Express software.
For each gene, real-time PCR was performed with samples
from at least two diﬀerent preparations using cDNA
generated from the reverse transcription of 2ug of total
RNA, in a 10-ml reaction. Negative controls for each gene
included no template (water) and no reverse transcriptase.
The PCR ampliﬁcation consisted of a 10-min denatura-
tion at 958C, followed by 40 cycles of ampliﬁcation (15s
at 958C, 60s at 608C). A standard curve was derived
from serial dilutions with an external cDNA obtained
from HeLa S3 or A549 cells for each gene. Relative
concentrations were expressed in arbitrary units. After
ampliﬁcation, amplicons were melted and the resulting
dissociation curve assessed to ensure a single product.
Relative quantiﬁcation of each of the genes of interest
was performed against a housekeeping gene, b-2-
microglobulin (B2M), according to Relative Standard
Curve Method as described previously (44). Several com-
monly employed housekeeping genes were assessed;
B2M was found to remain stable in expression in both
untreated and TMPyP4, TpPy or BMVC treated cells.
For all PCRs average of measurements done in triplicate
is reported. Averaged cell viability was around 88% for
100mM TMPyP4 or TMPyP2; 83% with 50mM BMVC;
82% with 10mM TpPy after 48h (MTT assay, average of
three independent observations).
PG4DNA motif searching, genomicmapping and analysis
PG4 DNA sequences were searched and mapped to the
promoters ( 1kb ﬂanking TSS) of diﬀerent genes as
described earlier (37) and mapped to the human genome
(UCSC hg16). Brieﬂy, PG4 DNA motifs were searched
with a program written using Perl. A general pattern:
G3-NL-G3-NL-G3-NL-G3, where G is guanine and N is
any nucleotide including G. The loop length (L) was
varied from one to seven. The same program was rerun
with cytosine instead of guanine to identify PG4 DNA
motifs on the minus strand and appropriately corrected
for orientation before mapping their position in the con-
text of genes.
Tissue-specific enrichment of geneset withPG4 DNA
inpromoters
Tissue speciﬁcity of genes harboring PG4 DNA within
putative promoters was checked in 79 human and 61
mouse tissues (45). Analysis was largely based on a pre-
viously described method (46). The expression data of
each gene across all tissues were ﬁrst normalized to be
mean 0 and variance 1 before ranking them as per their
normalized expression level in each tissue, hence generat-
ing tissue-speciﬁc ranked gene lists. Enrichment of expres-
sion (either up- or downregulated) of microarray gene set
in a particular tissue and its signiﬁcance was analyzed
from the ranked list of genes speciﬁc for that tissue after
evaluating the nonrandomness of ranks of microarray
gene list (sample set) within tissue-speciﬁc gene list (refer-
ence set), using the Mann–Whitney rank sum statistic (47).
After summing the ranks of sample set in reference set, we
tested the signiﬁcance of this rank sum against the rank
sum of control set (all genes in reference set, excluding
sample set genes). If m and 
2 are the mean and variance
of the control set than enrichment (z-score) of our sample
set is given by (m–S)/, which measures enrichment in
terms of number of standard deviations away from the
mean of the control set. A z-score of  3.5 is considered
to be signiﬁcant in the present study.
Pathway analysis
For GO analysis, UniGene symbols pertaining to diﬀer-
entially expressed genes were converted to UniProt IDs,
using Gene name converter (http://genemerge.bioteam.
net/convertgenenames.html). To examine enrichment or
depletion of genes in the diﬀerentially expressed sets, the
UniProt IDs were fed to the GO ToolBox [http://www.ge
neontology.com; (48)] to obtain the output using the
options—ontology: biological process and molecular
function; mode: all terms; reference: genome; evidence:
all–all evidence; species: Homo sapiens; GO-stats; statistic
test: hypergeometric; correction for multiple testing:
Bonferroni. Gene names of 850 genes out of 1161 diﬀer-
entially expressed genes (both up- and downregulated)
mapped to respective UniProt ID’s, using Gene name con-
verter, as explained above.
Search fororthologous geneswith conservedPG4 DNA
Orthologous gene data were downloaded from (NCBI
HomoloGene http://www.ncbi.nlm.nih.gov/). For every
PG4 DNA found within  1kb upstream or downstream
of TSS in a human promoter the respective orthologous
mouse and rat promoter was searched for a conserved
occurrence in a sequence window of 400 bases centered
at the human PG4 DNA. Conserved occurrence was
searched based on the PG4 DNA sequence pattern
described above whereby conservation is at the level of
the PG4 DNA structure and not necessarily primary
sequence. A compendium of the orthologous genes and
respective PG4 positions are given in the database—
EuQuad (http://quadbase.igib.res.in) (40).
RESULTS AND DISCUSSION
Evidence of widespread gene regulation by PG4DNA
To understand the physiological relevance of G4 DNA in
gene regulation we probed the whole genome for
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dies have shown that TMPyP4 is a potent G4 DNA-bind-
ing molecule within cells (15,18,20). In the most direct
demonstration of the role of G4 DNA in gene regulation,
it was shown that c-MYC (20) and PDGF-A (21) promoter
activity was repressed on using TMPyP4 to stabilize G4
DNA found within promoters, while destabilization of G4
DNA in the FMR1 gene could lead to increased transcrip-
tion (49). Furthermore, the repressive eﬀect of TMPyP4
on c-MYC promoter was lost on disrupting the G4 DNA
(20). Recent studies by us and others show prevalence of
G4 DNA within promoters of chicken (50), human and
related species (39,40,42,51) and several bacteria (37)
implicating widespread role of G4 DNA in regulation.
We performed whole-genome expression studies after
TMPyP4 treatment for 48h in two diﬀerent cell lines—
human cervix cancer cells (HeLa S3) and human lung
cancer cells (A549). For every TMPyP4-treated experi-
ment we ﬁrst independently conﬁrmed downregulation
of c-MYC by real-time quantitative PCR before hybrid-
ization to microarray slides to ascertain that the pre-
viously known eﬀect of TMPyP4 [i.e. suppression of
c-MYC (52)] was evident. Four replicates in each cell
line were performed and analyzed simultaneously, taking
results from both cell lines together, using Signiﬁcance
Analysis of Microarray [SAM (43), see ‘Material and
Methods’ section for details of analysis] to ﬁrst establish
the global eﬀect of G4 DNA-regulated genes. One thou-
sand one hundred and sixty-one genes were signiﬁcantly
up- or downregulated at  20% FDR as per the statistical
signiﬁcance test performed using SAM (Figure 1A, expres-
sion array results shown in Supplementary Figure 1 and
http://quadbase.igib.res.in/Geneexpression.html). Out of
the 1161 genes, 863 genes were upregulated while 298
genes downregulated (Figure 1B). It is expected that
observed genome-wide expression changes will primarily
be a result of both direct and indirect eﬀects of TMPyP4-
induced stabilization/destabilization of G4 DNA. In other
words, some genes will be directly aﬀected by binding of
TMPyP4 to G4 DNA within promoters and these genes in
turn may regulate several downstream genes. In order to
ﬁnd genes that were most likely to be regulated by G4
DNA, we examined the sequence around transcription
start sites (TSS) using a previously published computa-
tional method that detects DNA sequence patterns liable
to adopt G4 DNA forms (details of the algorithm used are
provided in the methods) (37). We found a total of 38757
PG4s within  1kb of TSS in 25706 annotated human
genes where 1550 or (3.9%) of PG4s are within exons,
4363 (11.2%) are in introns and 8490 (21.9%) within the
50UTRs. We noted 711 out of 1161 diﬀerentially expressed
genes (526/863 upregulated and 185/298 downregulated)
showed presence of at least one PG4 DNA forming
sequence within  1kb of TSS (Figure 1B). However,
we noted that the PG4 density (no. of PG4 DNA motifs
per gene) within 1kb of TSS of genes that responded
to TMPyP4 treatment was 1.05 fold higher than
expected by chance (though statistically signiﬁcant, see
Supplementary Information) suggesting that the correla-
tion between presence of PG4 DNA and the inﬂuence of
TMPyP4 is complex. This is not surprising given that
expression assays do not distinguish between direct
versus indirect eﬀects of treatment. Furthermore, the
putative nature of G4 DNA limits the likelihood of all
of them forming and/or responding to a binding molecule
at the same time. On the other hand, it may also be pos-
sible that intracellular eﬀect of TMPyP4 is limited.
Keeping these confounding factors in mind we addressed
this issue more directly using an experimental plan that
involves validation of the genome-wide expression data by
expression analysis of selected genes using RT-PCR using
other known G4 DNA binding molecules.
In order to validate the microarray data, we used quan-
titative RT-PCR. 12 genes showing signiﬁcant response in
microarray were picked randomly and their expression
measured by quantitative RT-PCR. In most cases (10
genes) results were consistent in terms of the up- or down-
regulation observed in microarray (Figure 1C).
In order to ascertain that the eﬀect of TMPyP4
was largely due to G4 DNA binding, we also used two
additional molecules whose binding with G4 DNA have
been reported. We selected the carbazole derivative
BMVC (Figure 2A) which was shown recently to bind
G4 DNA motifs in vivo within human telomeres
(10,52). The second molecule, 5,10,15,20-tetrakis
(R-pyridinio-p-methylphenyl)-21,23H-porphyrin tetra-
chloride (TpPy) is an analog of TMPyP4 with extended
aromatic side chains (Figure 2A). In previous reports,
TpPy was demonstrated to have speciﬁc binding aﬃnity
for the G-quartet due to the favorable   stacking ren-
dered by the aromatic side chain in TpPy. Quantitative
RT-PCR was used to check the eﬀect of BMVC and
TpPy on gene expression. Twelve genes were used for
this purpose including c-MYC (11 genes were from the
ones randomly selected for qRT-PCR with TMPyP4;
DHCR24, which gave no transcripts in A549 cells was
excluded). We noted with interest that for BMVC
(50mM) and TpPy (10mM) treatment, all the 12 genes
showed repressed levels, which were similar to the repres-
sion noted for TMPyP4 treatment in 10 genes (Figure 2B).
Treatments were done using 50 and 10mM of BMVC
and TpPy, respectively, as higher concentrations compro-
mised cell viability. For two genes, C5ORF6 and MTCP1,
eﬀect of TMPyP4 was opposite to that of TpPy and
BMVC.
For further validation of these observations, we
also used 5,10,15,20-tetra-(N-methyl-2-pyridyl)porphyrin
(TMPyP2). TMPyP2 is positional isomer of TMPyP4
where the position of the cationic substitution on the
periphery of the porphyrin is altered (Figure 2A). This
results in signiﬁcantly decreased aﬃnity for G4 DNA
and telomerase inhibition whereas its binding aﬃnity for
double-strand DNA is similar to that of TMPyP4 (54,55)
Keeping this in mind, we hypothesized that TMPyP2
would be a suitable negative control for G4 DNA binding
within cells vis-a`-vis TMPyP4. This was tested using qRT-
PCR of 12 genes (as selected above) after treatment with
TMPyP2. We ﬁrst noted that c-MYC expression did not
change signiﬁcantly on TMPyP2 treatment and was there-
fore considered as the endogenous control for relative
quantitation of gene expression. Further, expression of
eight other genes was very diﬀerent from that observed
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Figure 1. Genome-wide expression analysis shows wide-spread PG4 DNA-mediated gene regulation. (A) SAM plot showing overexpressed or
repressed genes at  20% FDR; (B) distribution of signiﬁcantly diﬀerentially expressed genes ( 20% FDR) in microarray based on presence/absence
of PG4 within  1kb from transcription start sites. (C) Validation of microarray results by quantitative RT-PCR. Ten out of twelve reactions tested
gave consistent change in expression on TMPyP4 treatment, in both cell lines. All selected genes (12) were at  20% FDR. Transcript level could not
be detected for DHCR24 gene in A549 cells.
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Figure 2. Gene expression change in presence of G4 DNA-binding ligands was consistent with TMPyP4 but not TMPyP2, which does not bind to
G4 DNA. (A) Scheme showing the structure of ligands used. Quantitative RT-PCR results 48h after treatment of A549 cells with BMVC/TpPy/
TMPyP4 (B) or TMPyP4/TMPyP2 (C). Average of at least three measurements is given for each PCR.
Nucleic Acids Research, 2009,Vol.37, No. 13 4199in TMPyP4 treatment (Figure 2C). In contrast to
TMPyP4 treatment, ﬁve of these genes were expressed at
1.2-fold or lower and two genes were expressed at
 1.3-fold on TMPyP2 treatment. However, we did note
that three of the 12 genes showed expression that was
similar to that of TMPyP4.
To understand the overall relevance in terms of biolog-
ical function, we asked whether diﬀerentially expressed
genes were signiﬁcantly over- or underrepresented in any
functional categories. The Gene Ontology (GO) database
(http://www.geneontology.org/) was used for this analysis.
Out of 1161 diﬀerentially expressed genes, 850 genes (for
which uniprot IDs were available) were used for GO ana-
lysis. Out of 850 genes, 631 genes were upregulated and
219 downregulated in the microarray experiment. In this
set of 850 genes, many were found to be signiﬁcantly
(P<0.05 after Bonferroni correction for multiple hypoth-
esis testing) overrepresented in functions related to intra-
cellular transport, cellular localization and protein
binding. In support of this, we noted a recent bioinfor-
matics study which found overrepresentation of G4 DNA
motifs in promoters of genes related to ‘cation transport’
(39), which is a subclassiﬁcation of ‘intracellular transport’
observed within the diﬀerentially expressed genes analyzed
by us. Another important functional class observed in
the previous report was ‘transcriptional activator activ-
ity’—we noted this at a slightly lower signiﬁcance level
(P=0.058). On the other hand, functions related to
receptor activity (transmembrane, rhodopsin-like and
G-protein-coupled receptors) were signiﬁcantly depleted
in the GO result obtained from analysis of the 850
genes. Depletion of PG4 DNA harboring genes in func-
tions related to G-protein-coupled- receptor protein sig-
naling pathway (P=2.46E-06) and receptor activity
(P=3.071E-04) was also observed before (39). All signif-
icant classes along with P-values are given in Supple-
mentary Table 1. Enriched functional classes observed
on using the genes that changed expression signiﬁcantly
(this study) were in many cases diﬀerent from those
observed in the earlier bioinformatics study based on pres-
ence of putative G4 DNA within 1kb of TSS (56). This is
not surprising given that the presence of putative G4
DNA may not always result in formation of the structural
motif(s). Alternatively, TMPyP4 interaction with G4
DNA may not be a necessary condition for regulatory
changes. In a recent bioinformatics study Du et al. (56)
showed correlation of potential quadruplex sequence
(PQS) present in downstream regions (+500 bases with
respect to TSS) with increased gene expression, which was
not noticed on considering upstream PQS within –500bp
of TSS. Based on this it was predicted that downstream
G4 DNA may be more relevant in the context of gene
expression. Our ﬁndings indicating experimentally deter-
mined gene expression that may be related to G4 DNA
presents an interesting way to test the above prediction.
We used all the genes that have shown signiﬁcant expres-
sion change in our data and harbor PG4 DNA and asked
whether diﬀerential presence of PG4 DNA could be seen
500 bases upstream or downstream of TSS. Any bias
toward presence of downstream PG4 vis-a`-vis upstream
PG4 would be in line with the prediction made by Du
et al. We noted 56.8% of all PG4s in the diﬀerentially
expressed genes occurred within 500 bases downstream
of TSS in contrast to 43.2% of PG4s, which were present
upstream. However, this does not appear to be signiﬁcant
when compared to all human genes with PG4 DNA within
500 bases of TSS where about 54% of the PG4s are found
downstream of TSS.
PG4 DNA is conservedwithin promoters of differentially
expressed genes
In addition to testing the role of PG4 DNA in genome-
wide expression we explored whether PG4 DNA within
promoters of genes were conserved in other related species
since biologically meaningful G4 DNA would most likely
be conserved. In our expression experiments we noted that
711 genes were diﬀerentially expressed ( 20% FDR) and
also harbored PG4 DNA within  1kb centered at TSS.
Expression of these genes was more likely to be inﬂuenced
by the presence of PG4 DNA. Therefore, we checked for
conservation of PG4 DNA found within these 711 pro-
moters. In keeping with our interest on the structural PG4
DNA, we considered conservation at the level of structure
and not sequence; in other words, conserved elements
would not have identical sequence but are most likely to
result in the G4 motif structure nevertheless. Conservation
of PG4 DNA that was found in human promoters (within
 1kb ﬂanking TSS) was checked within promoters of
orthologous mouse and rat genes. We deﬁned conserva-
tion as presence of PG4 DNA within  200 bases ﬂanking
the PG4 DNA on human in corresponding gene pairs.
The 200 base window considered on either side of the
PG4 DNA occurrence was based on a previous study
which showed that most cis-regulatory sites are conserved
within  400 bases in whole-genome comparison of
human, mouse, rat and dog genomes (46). Orthologs in
both mouse and rat was found for only 479 out of the 711
genes. Out of the 479 ‘orthologous’ promoters thus iden-
tiﬁed, 71 promoters had at least one conserved PG4 DNA
in all the three species, human, mouse and rat (57 expected
by chance, P=0.6; w test). List of these genes and their
signiﬁcance level in the microarray analysis (FDR)
(showing the reliability with which the changed level of
expression was determined on treatment with TMPyP4)
are given in Supplementary Table 2. In order to ﬁnd out
whether the 71 genes belonged to any particular functional
class we performed GO analysis. Signiﬁcant overrepresen-
tation was observed in three biological processes, pro-
tein binding, nucleotide metabolism and biosynthesis
(P<0.05; after Bonferroni correction). Protein binding
was also overrepresented in the GO analysis done
with all 1161 genes diﬀerentially expressed on TMPyP4
treatment.
Intramolecular G4 DNA structures are single-stranded
fold back forms and thus their formation would require
strand separation within a duplex genome. In this context
dynamics of G4 DNA folding has been addressed by var-
ious groups, under in vitro conditions in the presence of
the second strand (57,58). Therefore, mere occurrence of
sequence that forms G4 DNA may be of limited func-
tional signiﬁcance. In this context, conserved PG4 DNA
4200 Nucleic Acids Research, 2009, Vol. 37,No. 13was most likely to be functionally relevant as cis-regula-
tory motifs. Based on these, we reasoned that presence of
a unique functional regulatory site was expected to show
largely coordinated expression of a group of genes across
speciﬁc tissues (46). With this in mind, we checked tissue-
speciﬁc expression of the 71 genes having conserved PG4
DNA within promoters in the expression proﬁle of 79
human tissues reported earlier (45). For this analysis,
expression of the group of 71 genes was compared against
randomly picked genes to check whether the expression of
the 71 genes when taken together changed in a statistically
signiﬁcant manner relative to random sets in a given tissue
(see ‘Material and Methods’ section). Interestingly, 72 out
of 79 tissues exhibited signiﬁcantly changed expression
(either up- or downregulation) of the 71 genes that
harbor conserved PG4 DNA (z-score>3.5; P<0.0001
as shown in Figure 3). Genes (200) without a PG4 DNA
(within  5kb of TSS) or no PG4 DNA within  1kb of
TSS showed no signiﬁcant enrichment (Figure 3, human
tissue expression proﬁle). Therefore, it is likely that PG4
DNA presence near TSS is aﬀecting tissue-speciﬁc expres-
sion while presence of PG4 DNA in regions further
upstream or downstream may not be directly involved.
However, more work is required to rule out the eﬀect of
other cellular modulators [several G4 DNA-binding pro-
teins are known (59) that may be involved in a tissue-
speciﬁc fashion]. As the PG4 DNA were conserved
within 71 ‘orthologous’ mouse promoters, we further
validated our observations by checking tissue-speciﬁc
expression of the 71 mouse orthologous genes in mouse
tissues. For this analysis we took gene expression micro-
array data available for 61 normal mouse tissues (45) and
performed a similar analysis as discussed above. Here
also we observed that the 71 genes with conserved
PG4 DNA within promoters showed signiﬁcantly changed
expression in 56 out of the 61 tissues analyzed
(z-score>3.5, P<0.0001; Figure 3) in line with our
previous observation.
In a previous genome-wide comparative bioinformatics
study involving Escherichia coli and 17 other bacterial
genomes we observed striking enrichment of G4 DNA
within promoters (37). In silico analysis also indicated
that G4 DNA may regulate more than 1000 genes in the
growth phase of E. coli when supercoiling results in for-
mation of single strands (37). In support of this, formation
of non-B DNA motifs have been demonstrated to regulate
several operons in E. coli when the duplex character of the
genome is destabilized giving single-stranded forms (60).
Emerging evidence shows G4 DNA enrichment is wide-
ranging in bacterial promoters [we studied 146 diﬀerent
microbes (40)]. Recent evidence also supports enrichment
of G4 DNA within promoters of human and other related
genomes (39,40,51). These ﬁndings along with demon-
strated experimental evidence of the role of G4 DNA in
regulation of the c-MYC (20) and PDGF-A (21) genes
strongly implicate G4 DNA as regulatory elements. In a
recently conducted genome-wide comparative bioinfor-
matics study involving human, chimpanzee, mouse and
rat, we asked whether G4 DNA motifs preserve character-
istics of global cis-regulatory elements. We noted with
interest that PG4 DNA found within human promoters
were conserved with more than 700 mouse and rat pro-
moters of orthologous genes; we also performed genome-
wide expression experiments using TMPyP4 in cervical
epithelial carcinoma (HeLa S3) cells where about 69
genes responded signiﬁcantly at 48h (42).
In the current study we ﬁrst extend our previous
ﬁndings by validating TMPyP4-mediated genome-wide
expression in a second cell line (A549) wherein a combined
analysis of the microarray results (considering both the
cell lines together) demonstrated an extensive repertoire
of genes that could be under G4 DNA regulation support-
ing previous bioinformatics predictions (39,40,51). Many
genes, which changed expression also harbored PG4
DNA forming sequence (identiﬁed using bioinformatics
approaches) in their promoters supporting the role of
G4 DNA as a cis-regulatory element. To further support
this, we examined and found that 71 genes that responded
signiﬁcantly in microarrays also conserved PG4 DNA
within promoters of orthologous genes in related species
(mouse and rat). In this study we noted both upregulation
as well as downregulation of gene expression as a result of
TMPyP4 treatment. It is interesting to consider the possi-
bilities as both stabilization and destabilization of the G4
DNA motif on interaction with TMPyP4 have been
observed. In cases where G4 DNA positively inﬂuences
gene expression [e.g. insulin-linked polymorphin region
upstream of insulin gene (19)], stabilization may lead to
enhanced expression and conversely, disruption of the G4
DNA would result in down regulation. On the other
hand, in cases like c-MYC (20) and PDGF-A (21) where
the G4 DNA motif may be a negative regulator,
TMPyP4-mediated stabilization would result in decreased
promoter activity. Destabilization in this case would again
result in upregulated expression of the gene. In all the
above mechanistic models, inﬂuence of the G4 DNA
motif as a cis-regulatory unit is central. Moreover, consid-
ering that other intracellular factors may associate directly
or indirectly with G4 DNA many other mechanistic
models can be envisaged.
Based on the ﬁndings presented here, it is tempting to
speculate widespread inﬂuence of G4 DNA on gene regu-
lation as a result of perturbation in chromatin, thereby
suggesting a mechanistic link between local and global
chromosomal structure to speciﬁc gene regulation events.
This view is supported by observations indicating that
non-B DNA structures, resulting from supercoiling
induced during transcription, recruit structure-speciﬁc reg-
ulatory factors (61). Our study suggests such a possibility
at a genome-wide level and warrants further experiments
to speciﬁcally probe role of G4 DNA at a molecular
level, particularly in connection with factors that may be
involved directly with G4 DNA during transcription. In
this context it is noteworthy that the nonmetastatic pro-
tein NM23-H2, which is a transcriptional activator of
c-MYC (62), binds a G4 DNA structure present in the
promoter of c-MYC (63). When considered with recent
reports that add to the repertoire of experimentally char-
acterized G4 DNA found within human gene promoters
(20,21,25,64), an interesting possibility of another dimen-
sion to gene regulation is revealed.
Nucleic Acids Research, 2009,Vol.37, No. 13 4201 Mouse tissues (61 tissues) Human tissues (79 tissues)
Figure 3. Tissue-speciﬁc expression of genes with conserved PG4 DNA in promoters. 71 genes show enriched expression (either up- or down-
regulated) in 72/79 human and 56/61 mouse (normal) tissues. Statistical tissue-speciﬁc expression enrichment (z-score>3.5, P<0.0001) is repre-
sented in pseudo-color for both human and mouse tissues. Genes (200) without PG4 DNA in  1kb or  5kb (centered at TSS) do not show
enrichment of expression in 79 human tissues (Figure 1).
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